[The screening of the inhibitors of the human cytochrome P450(51) (CYP51A1): the plant and animal structural lanosterol's analogs]

L. A. Kaluzhsiy, O. V. Gnedenko, A. A. Gilep, N. V. Strushkevich, T. V. Shkel, M. A. Chernovetsky, A. S. Ivanov, A. V. Lisitsa, A. S. Usanov, V. A. Stonik, A. I. Archakov

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)

Abstract

The cholesterol biosynthesis regulation is the important part of the hypercholesterolemia diseases therapy. The inhibition of the post-squalene cholesterol biosynthesis steps provide the alternative to classic statin therapy. Sterol-14a-demethylase (CYP51) is one of the hypothetical targets for it. In this work the screening of the ability to interact with human CYP51 (CYP51A1) for the nature low-weight compounds with steroid-like scaffold were performed by integration of the surface plasmon resonance biosensor and spectral titration methods. The results of the selection were 4 compounds (betulafolientriol, holothurin A, teasaponin, capsicoside A) witch had high affinity to the CYP51A1 active site. These data extend the range of compounds which may be used as specific inhibitors of CYP51 and give the permission to suggest the dynamic of the enzyme.

Original languageEnglish
Pages (from-to)528-537
Number of pages10
JournalBiomeditsinskaya Khimiya
Volume60
Issue number5
Publication statusPublished - 2014
Externally publishedYes

Keywords

  • CYP51
  • cytochrome P450
  • optical biosensor
  • spectral titration
  • surface plasmon resonance
  • triterpenes

Fingerprint

Dive into the research topics of '[The screening of the inhibitors of the human cytochrome P450(51) (CYP51A1): the plant and animal structural lanosterol's analogs]'. Together they form a unique fingerprint.

Cite this